Cargando…

Telomerase activity in plasma cell dyscrasias

Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, D, Zheng, C, Bergenbrant, S, Holm, G, Björkholm, M, Yi, Q, Gruber, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363791/
https://www.ncbi.nlm.nih.gov/pubmed/11237381
http://dx.doi.org/10.1054/bjoc.2000.1655
_version_ 1782153792413761536
author Xu, D
Zheng, C
Bergenbrant, S
Holm, G
Björkholm, M
Yi, Q
Gruber, A
author_facet Xu, D
Zheng, C
Bergenbrant, S
Holm, G
Björkholm, M
Yi, Q
Gruber, A
author_sort Xu, D
collection PubMed
description Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and plasma cell leukaemia (PCL). All 5 patients with MGUS exhibited normal levels of telomerase activity in their plasma cells. Elevated telomerase activity was found in the samples from 21/27 patients with MM and 4/4 with PCL. In addition, 4 myeloma cell lines all expressed high levels of telomerase activity. The expression of telomerase reverse transcriptase (hTERT) and telomerase RNA template (hTER) was positively associated with the levels of telomerase activity in MM/PCL. Tankyrase expression was upregulated, concomitant with the induction of hTERT and activation of telomerase in MM/PCL. The present findings indicate that MGUS cells may not be immortalized and that activation of telomerase plays a role in the malignant transformation from MGUS to MM. © 2001 Cancer Research Campaign http://www.bjcancer.com
format Text
id pubmed-2363791
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23637912009-09-10 Telomerase activity in plasma cell dyscrasias Xu, D Zheng, C Bergenbrant, S Holm, G Björkholm, M Yi, Q Gruber, A Br J Cancer Regular Article Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and plasma cell leukaemia (PCL). All 5 patients with MGUS exhibited normal levels of telomerase activity in their plasma cells. Elevated telomerase activity was found in the samples from 21/27 patients with MM and 4/4 with PCL. In addition, 4 myeloma cell lines all expressed high levels of telomerase activity. The expression of telomerase reverse transcriptase (hTERT) and telomerase RNA template (hTER) was positively associated with the levels of telomerase activity in MM/PCL. Tankyrase expression was upregulated, concomitant with the induction of hTERT and activation of telomerase in MM/PCL. The present findings indicate that MGUS cells may not be immortalized and that activation of telomerase plays a role in the malignant transformation from MGUS to MM. © 2001 Cancer Research Campaign http://www.bjcancer.com Nature Publishing Group 2001-03 /pmc/articles/PMC2363791/ /pubmed/11237381 http://dx.doi.org/10.1054/bjoc.2000.1655 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Xu, D
Zheng, C
Bergenbrant, S
Holm, G
Björkholm, M
Yi, Q
Gruber, A
Telomerase activity in plasma cell dyscrasias
title Telomerase activity in plasma cell dyscrasias
title_full Telomerase activity in plasma cell dyscrasias
title_fullStr Telomerase activity in plasma cell dyscrasias
title_full_unstemmed Telomerase activity in plasma cell dyscrasias
title_short Telomerase activity in plasma cell dyscrasias
title_sort telomerase activity in plasma cell dyscrasias
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363791/
https://www.ncbi.nlm.nih.gov/pubmed/11237381
http://dx.doi.org/10.1054/bjoc.2000.1655
work_keys_str_mv AT xud telomeraseactivityinplasmacelldyscrasias
AT zhengc telomeraseactivityinplasmacelldyscrasias
AT bergenbrants telomeraseactivityinplasmacelldyscrasias
AT holmg telomeraseactivityinplasmacelldyscrasias
AT bjorkholmm telomeraseactivityinplasmacelldyscrasias
AT yiq telomeraseactivityinplasmacelldyscrasias
AT grubera telomeraseactivityinplasmacelldyscrasias